COVID-19 and Rheumatology
Total Page:16
File Type:pdf, Size:1020Kb
Annals of the Rheumatic Diseases publishes original work on all aspects of rheumatology ARDThe EULAR Journal Editor Josef S Smolen (Austria) and disorders of connective tissue. Laboratory Associate Editors Francis Berenbaum (France) and clinical studies are equally welcome Dimitrios Boumpas (Greece) Gerd Burmester (Germany) Editorial Board Mary Crow (USA) Daniel Aletaha (Austria) Rik Lories (Belgium) Kimme Hyrich (UK) Johan Askling (Sweden) Ingrid Lundberg (Sweden) Contact Details Rik Lories (Belgium) Sang-Cheol Bae (Korea) Gary MacFarlane (UK) Iain McInnes (UK) Xenofon Baraliakos (Germany) Xavier Mariette (France) Editorial Office Thomas Pap (Germany) Anne Barton (UK) Alberto Martini (Italy) Annals of the Rheumatic Diseases David Pisetsky (USA) Maarten Boers (The Netherlands) Marco Mattuci Cerinic (Italy) BMJ Journals, BMA House, Tavistock Square Désirée van der Heijde Maxine Breban (France) Dennis McGonagle (UK) London WCIH 9JR,UK (The Netherlands) Matthew Brown (Australia) Fred Miller (USA) Kazuhiko Yamamoto (Japan) Maya Buch (UK) Peter Nash (Australia) E: [email protected] Loreto Carmona (Spain) Michael Nurmohamed (The Methodological and Statistical Carlo Chizzolini (Switzerland) Netherlands) Production Editor Advisor Bernard Combe (France) Caroline Ospelt (Switzerland) Teresa Jobson Philip Conaghan (UK) Stian Lydersen (Norway) Monika Østensen (Norway) E: [email protected] Maurizio Cutolo (Italy) Constatino Pitzalis (UK) Social Media Advisors Nicola Dalbeth (Australia) Alessia Alunno (Italy) Jane Salmon (USA) EULAR Christian Dejaco (Austria) Georg Schett (Germany) Mary Canavan (Ireland) Oliver Distler (Switzerland) EULAR Executive Secretariat Thomas Dörner (Germany) José da Silva (Portugal) Meghna Jani (UK) Hendrik Schulze-Koops (Germany) Seestrasse 240, 8802 Kilchberg, Switzerland Elena Nikiphorou (UK) Dirk Elewaut (Belgium) Axel Finckh (Switzerland) Nan Shen (China) E: [email protected] Caroline Ospelt (Switzerland) Greg Silverman (USA) www.eular.org Christophe Richez (France) Rebecca Fischer-Betz (Germany) Roy Fleischmann (USA) Alexander So (Switzerland) Paul Studenic (Austria) Mary Goldring (USA) Hiroshi Takayanagi (Japan) Customer support Laure Gossec (France) Tsutomu Takeuchi (Japan) For general queries and support with existing and Guidelines for Authors and Yoshiya Tanaka (Japan) Walter Grassi (Italy) new subscriptions: Reviewers Ahmet Gül (Turkey) Dimitrios Vassilopoulos (Greece) Full instructions are available Frederic Houssiau (Belgium) Douglas Veale (Ireland) W: support.bmj.com online at http://ard.bmj.com/ Tom Huizinga (The Netherlands) Jiri Vencovsky (Czech Republic) T: +44 (0)20 7111 1105 Arthur Kavanaugh (USA) Ronald van Vollenhoven (Sweden) E: [email protected] pages/authors. Articles must Margreet Kloppenburg (The Erwin Wagner (Spain) be submitted electronically at Netherlands) Michael Ward (USA) Self-archiving and permissions http://mc.manuscriptcentral. Robert Landewé (The Netherlands) Kevin Winthrop (USA) W: bmj.com/company/products-services/ Zhan-Gou Li (China) Huji Xu (China) com/ard. Authors retain copyright rights-and-licensing/ but are required to grant ARD Chairman of Advisory E: [email protected] an exclusive licence to publish. Committee (http://ard.bmj.com/pages/authors/). Johannes Bijlsma Advertising (The Netherlands) W: bmj.com/company/for-advertisers- and-sponsor/ Advisory Committee Ferry Breedveld (The Netherlands) Zhan-guo Li (China) Display Advertising ROW Marco Matucci Cerinic (Italy) Peter Lipsky (USA) Sophie Fitzsimmons Michael Doherty (UK) Sir Ravinder Maini (UK) T: +44 (0)20 3655 5612 Maxime Dougados (France) Emilio Martín-Mola (Spain) Paul Emery (UK) Haralampos Moutsopoulos E: [email protected] Daniel Furst (USA) (Greece) Online Advertising ROW Steffen Gay (Switzerland) Karel Pavelka (Czech Republic) Marc Hochberg (USA) Yehuda Shoenfeld (Israel) Marc Clifford Joachim Kalden (Germany) Leo van de Putte (The Netherlands) T: +44 (0) 20 3655 5610 Edward Keystone (Canada) Frank Wollheim (Sweden) E: [email protected] Lars Klareskog (Sweden) Anthony Woolf (UK) Tore Kvien (Norway) Display & Online Advertising Americas American Medical Communications (AMC) T: +1 973 214 4374 Subscription Information E: [email protected] ARD is published monthly; subscribers receive all supplements Reprints ISSN 0003-4967 (print); 1468-2060 (online) Author Reprints Institutional Rates 2020 Personal Rates 2020 BMJ Reprints Team E: [email protected] Print Print (includes online access at no additional cost) Commercial Reprints ROW £1088 £450 Nadia Gurney-Randall M: +44 07866 262344 Online Online only £192 E: [email protected] Site licences are priced on FTE basis and allow access by the whole institution. Details available EULAR congress delegates Commercial Reprints Americas online at http://journals.bmj.com/content/subscribers Delegates receive a Continuous Professional Ray Thibodeau or contact the Subscription Manager in the UK (see Development package that includes a 12 month T: +1 267 895 1758 above right) complimentary subscription to ARD in print M: +1 215 933 8484 and/or online E: [email protected] Personal print or online only and institutional print subscriptions may be purchased online at http://journals.bmj.com/content/ For all other journal contacts subscribers (payment by Visa/Mastercard only) ard.bmj.com/contact-us Residents of some EC countries must pay VAT; for details, call us or visit http://journals.bmj.com/content/subscribers For more information on subscription rates or to subscribe online please visit ard/bmj.com/pages/contact-us/ Contents Volume 79 Issue 5 | ARD May 2020 ARDThe Eular Journal Impact Factor: 14.299 Editorial Spondyloarthritis may 2020 Volume 79 Issue 5 551 COVID-19 and rheumatology: first steps 595 Dual neutralisation of interleukin-17A and 79 5 Annals of the Volume 79 Issue 5 Volume 551–676 Pages Rheumatic towards a different future? interleukin-17F with bimekizumab in patients Diseases I B McInnes with active ankylosing spondylitis: results The EULAR Journal from a 48-week phase IIb, randomised, AnnAls of RheumAtIc DIseAses of RheumAtIc AnnAls double-blind, placebo-controlled, dose-ranging Viewpoint study 553 Disruptive innovation in rheumatology: new D van der Heijde, L S Gensler, A Deodhar, networks of global public–private partnerships X Baraliakos, D Poddubnyy, A Kivitz, M K Farmer, D Baeten, N Goldammer, J Coarse, M Oortgiesen, the home for innovative are needed to take advantage of scientific m rheumatology research ay 2020 ard.bmj.com progress M Dougados T WJ Huizinga, V M Holers, J Anolik, M B Brenner, C D Buckley, V Bykerk, S E Connolly, K D Deane, 605 Reactive arthritis and other musculoskeletal Editor J Guo, M Hodge, S Hoffmann, F Nestle, C Pitzalis, symptoms associated with acquisition of Josef S Smolen S Raychaudhuri, K Yamamoto, Z Li, L Klareskog diarrhoeagenic Escherichia coli (DEC) Associate Editors R Tuompo, T Lääveri, T Hannu, S H Pakkanen, Francis Berenbaum J Kirveskari, M Leirisalo-Repo, A Kantele Dimitrios Boumpas Gerd Burmester Rheumatoid arthritis Mary Crow 556 Two-year cost-effectiveness of different Kimme Hyrich Rik Lories COBRA-like intensive remission induction Systemic lupus erythematosus Iain McInnes schemes in early rheumatoid arthritis: a 612 Impact of the new American College of Thomas Pap David Pisetsky piggyback study on the pragmatic randomised Cardiology/American Heart Association Désirée van der Heijde controlled CareRA trial definition of hypertension on atherosclerotic Kazuhiko Yamamoto S Pazmino, A Boonen, V Stouten, D De Cock, J Joly, vascular events in systemic lupus Editorial office K Van der Elst, R Westhovens, P Verschueren erythematosus Annals of the Rheumatic Diseases K Tselios, D D Gladman, J Su, M Urowitz BMJ Publishing Group Ltd 566 Risk of neuroinflammatory events in arthritis BMA House Tavistock Square patients treated with tumour necrosis factor London WCIH 9JR,UK alpha inhibitors: a collaborative population- T: +44 (0)20 3655 5889 Systemic sclerosis based cohort study from Denmark and Sweden E: [email protected] 618 Riociguat in patients with early diffuse Twitter: @ARD_BMJ T I Kopp, B Delcoigne, E V Arkema, R K Jacobsen, ISSN: 0003-4967 (print) M Magyari, E H Ibfelt, H Locht, F Sellebjerg, cutaneous systemic sclerosis (RISE-SSc): ISSN: 1468-2060 (online) R L Cordtz, D V Jensen, J Askling, L Dreyer randomised, double-blind, placebo-controlled Disclaimer: The Editor of ARD has been granted multicentre trial editorial freedom and ARD is published in 573 Immunosuppression and the risk of D Khanna, Y Allanore, C P Denton, M Kuwana, accordance with editorial guidelines issued by M Matucci-Cerinic, J E Pope, T Atsumi, R Bečvář, the World Association of Medical Editors and the readmission and mortality in patients with L Czirják, E Hachulla, T Ishii, O Ishikawa, Committee on Publication Ethics. ARD is primarily rheumatoid arthritis undergoing hip fracture, intended for healthcare professionals and its S R Johnson, E De Langhe, C Stagnaro, V Riccieri, content is for information only. The Journal is abdominopelvic and cardiac surgery published without any guarantee as to its accuracy E Schiopu, R M Silver, V Smith, V Steen, or completeness and any representations or M D George, J F Baker, K L Winthrop, W Stevens, G Szücs, M-E Truchetet, M Wosnitza, warranties are expressly excluded to the fullest S D Goldstein, E Alemao, L Chen, Q Wu, F Xie, K Laapas, J de Oliveira Pena, Z Yao, F Kramer, extent permitted by law. Readers are advised to J R Curtis independently verify any information